Documento de consenso sobre el manejo de la dislipemia aterogénica de la Sociedad Española de Arteriosclerosis
- 1 March 2017
- journal article
- Published by Elsevier in Clínica e Investigación en Arteriosclerosis
- Vol. 29 (2) , 86-91
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- La auténtica dimensión del colesterol-no-HDL: colesterol aterogénicoClínica e Investigación en Arteriosclerosis, 2016
- Non-HDL Cholesterol and TriglyceridesArteriosclerosis, Thrombosis, and Vascular Biology, 2016
- Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional studyCardiovascular Diabetology, 2016
- 2016 European Guidelines on cardiovascular disease prevention in clinical practiceEuropean Heart Journal, 2016
- Importancia de la dislipidemia en la enfermedad cardiovascular: un punto de vistaClínica e Investigación en Arteriosclerosis, 2015
- Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart StudyAmerican Heart Journal, 2014
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With StatinsJAMA, 2012
- Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es StudyDiabetologia, 2011
- Management of Dyslipidemia in the Metabolic SyndromeAmerican Journal of Cardiovascular Drugs, 2007
- Metabolic syndrome: A marker of patients at high cardiovascular riskCanadian Journal of Cardiology, 2006